C12Y 302/0102
Alpha-glucosidase
Official title: Alpha-glucosidase (3.2.1.20)
C12Y302/0102 (Alpha-glucosidase) appears on 213 US grants and 373 published applications in this corpus.
Search patents in C12Y- Granted patents
- 213
- Published applications
- 373
- Assignees
- 155
- Inventors
- 541
- Latest grant
- 21 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1988 | 2 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 3 | 0 |
| 1998 | 3 | 0 |
| 1999 | 3 | 0 |
| 2000 | 2 | 0 |
| 2001 | 3 | 3 |
| 2002 | 4 | 6 |
| 2003 | 3 | 7 |
| 2004 | 2 | 7 |
| 2005 | 0 | 2 |
| 2006 | 3 | 9 |
| 2007 | 3 | 4 |
| 2008 | 2 | 10 |
| 2009 | 4 | 11 |
| 2010 | 7 | 6 |
| 2011 | 3 | 6 |
| 2012 | 5 | 10 |
| 2013 | 7 | 12 |
| 2014 | 6 | 8 |
| 2015 | 9 | 12 |
| 2016 | 12 | 18 |
| 2017 | 5 | 22 |
| 2018 | 13 | 21 |
| 2019 | 11 | 25 |
| 2020 | 17 | 20 |
| 2021 | 15 | 29 |
| 2022 | 19 | 24 |
| 2023 | 11 | 27 |
| 2024 | 11 | 19 |
| 2025 | 16 | 36 |
| 2026 | 7 | 19 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method for selection of high M6P recombinant proteins21 Jul 2026US 12,686,859 B2Amicus Therapeutics, Inc.
- Targeting peptides for directing adeno-associated viruses (AAVs)16 Jun 2026US 12,653,904 B2California Institute of Technology
- Sugar composition containing cyclic tetrasaccharide, use thereof, and production method therefor2 Jun 2026US 12,644,142 B2Nagase Viita Co., Ltd.
- Immunomodulating gene therapy26 May 2026US 12,636,302 B2Duke University
- Formulations comprising recombinant acid α-glucosidase12 May 2026US 12,622,952 B2Amicus Therapeutics, Inc.
- Method for selection of high m6p recombinant proteins1 Oct 2026US 2026/0297549 A1Amicus Therapeutics, Inc.
- Recombinant adeno-associated viral vector for gene delivery3 Sep 2026US 2026/0258445 A1Abeona Therapeutics Inc.
- Compositions and methods for treating late-onset pompe disease30 Jul 2026US 2026/0216302 A1Genzyme Corporation
- Gene Therapy Constructs for the Treatment of Pompe Disease30 Jul 2026US 2026/0216373 A1Amicus Therapeutics, Inc.
- Increasing the availability of fermentable sugars in fermentations30 Jul 2026US 2026/0218248 A1Danisco US Inc.
Most cited
By later US patents
- Adeno-associated virus vectors comprising a gene encoding a lyosomal enzyme144US 5,962,313 AAvigen, Inc. · 1999
- Hybrid molecules having translocation region and cell-binding region126US 5,668,255 ASeragen, Inc. · 1997
- Methods for delivering DNA to muscle cells using recombinant adeno-associated virus vectors119US 5,858,351 AAvigen, Inc. · 1999
- Lysosomal proteins produced in the milk of transgenic animals92US 6,118,045 AAcademic Hospital · 2000
- Hybrid molecules having translocation region and cell-binding region85US 6,022,950 ASeragen, Inc. · 2000